Abifadel M, et al.: Mutations in PCSK9 cause autosaomal dominant hypercholesterolemia. Nat Genet 34:154-156, 2003
Cohen JC, et al. :Sequence variations in PCSK9, low LDL, and protection against Coronary Heart disease. N Engl J Med 354: 1264-1272, 2006
Vlachopoulos C, et al.:Prediction of cardiovascular events with levels of protein convertase subtilisin/kexin ype 9: A systematic review and meta-analysis. Atherosclerosis 252:50-60, 2016
Dadu RT, et al.:Lipid lowering with PCSK9 inhibitors. Nat Rev Cardiol 11:563-575, 2014